EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epilepsy is an important feature of KBG syndrome associated with poorer developmental outcome

Nathan Buijsse iD, Floor E Jansen, Charlotte W Ockeloen, Marjan J A van Kempen, Shimriet Zeidler, Marjolein H Willemsen, Emanuela Scarano, Sonia Monticone, Evelien Zonneveld-Huijssoon, Karen J Low, Allan Bayat iD, Sanjay M Sisodiya iD und 8 weitere

Epilepsia Open · 2023

DOI: 10.1002/epi4.12799 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia Open, 2023. Verfasst von Nathan Buijsse und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Abnormalities, Multiple, Intellectual Disability, Bone Diseases, Developmental, Tooth Abnormalities. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this study was to describe the epilepsy phenotype in a large international cohort of patients with KBG syndrome and to study a possible genotype–phenotype correlation.

Methods

We collected data on patients with ANKRD11 variants by contacting University Medical Centers in the Netherlands, an international network of collaborating clinicians, and study groups who previously published about KBG syndrome. All patients with a likely pathogenic or pathogenic ANKRD11 variant were included in our patient cohort and categorized into an “epilepsy group” or “non‐epilepsy group”. Additionally, we included previously reported patients with (likely) pathogenic ANKRD11 variants and epilepsy from the literature.

Results

We included 75 patients with KBG syndrome of whom 26 had epilepsy. Those with epilepsy more often had moderate to severe intellectual disability (42.3% vs 9.1%, RR 4.6 [95% CI 1.7–13.1]). Seizure onset in patients with KBG syndrome occurred at a median age of 4 years (range 12 months – 20 years), and the majority had generalized onset seizures (57.7%) with tonic–clonic seizures being most common (23.1%). The epilepsy type was mostly classified as generalized (42.9%) or combined generalized and focal (42.9%), not fulfilling the criteria of an electroclinical syndrome diagnosis. Half of the epilepsy patients (50.0%) were seizure free on anti‐seizure medication (ASM) for at least 1 year at the time of last assessment, but 26.9% of patients had drug‐resistant epilepsy (failure of ≥2 ASM). No genotype–phenotype correlation could be identified for the presence of epilepsy or epilepsy characteristics. Significance Epilepsy in KBG syndrome most often presents as a generalized or combined focal and generalized type. No distinctive epilepsy syndrome could be identified. Patients with KBG syndrome and epilepsy had a significantly poorer neurodevelopmental outcome compared with those without epilepsy. Clinicians should consider KBG syndrome as a causal etiology of epilepsy and be aware of the poorer neurodevelopmental outcome in individuals with epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abnormalities, MultipleIntellectual DisabilityBone Diseases, DevelopmentalTooth AbnormalitiesEpilepsy, GeneralizedHumansInfantFaciesRepressor ProteinsTranscription Factors

Stichwörter der Autor:innen

ANKRD11 genegenotype-phenotype correlationneurodevelopmentseizure

Substanzen

Repressor ProteinsTranscription Factors

Autor:innen und Institutionen

  • Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Pediatric Neurology, Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Department of Pediatrics, St. Orsola-Malpighi Hospital, Bologna, Italy.
  • Department of Pediatrics, Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy.

ORCID-Profile: Nathan Buijsse, Allan Bayat, Sanjay M Sisodiya, Debopam Samanta, Gaetan Lesca

Zitieren

APA

Buijsse, N., Jansen, F. E., Ockeloen, C. W., van Kempen, M. J. A., Zeidler, S., Willemsen, M. H., Scarano, E., Monticone, S., Zonneveld-Huijssoon, E., Low, K. J., Bayat, A., Sisodiya, S. M., Samanta, D., Lesca, G., de Jong, D., Giltay, J. C., Verbeek, N. E., Kleefstra, T., Brilstra, E. H., & Vlaskamp, D. R. M. (2023). Epilepsy is an important feature of KBG syndrome associated with poorer developmental outcome. Epilepsia Open. https://doi.org/10.1002/epi4.12799

Vancouver

Buijsse N, Jansen FE, Ockeloen CW, van Kempen MJA, Zeidler S, Willemsen MH, et al. Epilepsy is an important feature of KBG syndrome associated with poorer developmental outcome. Epilepsia Open. 2023. doi:10.1002/epi4.12799

BibTeX
@article{Buijsse2023,
  author = {Buijsse, Nathan and Jansen, Floor E and Ockeloen, Charlotte W and van Kempen, Marjan J A and Zeidler, Shimriet and Willemsen, Marjolein H and Scarano, Emanuela and Monticone, Sonia and Zonneveld-Huijssoon, Evelien and Low, Karen J and Bayat, Allan and Sisodiya, Sanjay M and Samanta, Debopam and Lesca, Gaetan and de Jong, Danielle and Giltay, Jaqcues C and Verbeek, Nienke E and Kleefstra, Tjitske and Brilstra, Eva H and Vlaskamp, Danique R M},
  title = {Epilepsy is an important feature of KBG syndrome associated with poorer developmental outcome},
  journal = {Epilepsia Open},
  year = {2023},
  doi = {10.1002/epi4.12799}
}
Kostenlos starten →